Optomeditech Ltd, an Espoo, Finland-based developer of a light-guided intravenous catheter system, raised $2.5m in funding.
Earlier this year, the company secured the ISO 13485 Quality Management System certificate and CE-mark for its OptiVein® system, issued by BSI from United Kingdom as the Notified Body.
Led by Amiel Rubinstein, CEO, Optomeditech is the developer of OptiVein® , a light-guided intravenous catheter system to increase the first attempt success rate in IV cannulation – the most common invasive procedure in healthcare. The system works by integrating a light guide into the IV catheter needle. As the needle tip penetrates the surrounding tissue, the light provides illumination for better information on the vein location. As the needle tip penetrates the vein, the light disappears immediately to signal the exact moment of penetration.